The department of Lymphoma/Myeloma has strong programs in both clinical and basic science research. Our clinical trials test new drugs and therapies and novel combinations of standard drugs, and drugs with unique mechanisms of actions. Our translational research program is dedicated to turning the discoveries of basic science, from fields such as molecular science and genetics, into effective treatments. Among current areas of investigation: tumor vaccines, new antibodies, the interaction of Hodgkin disease cells and normal cells, specific viruses which may cause lymphomas, and potential development of new small molecule signal transduction inhibitors to treat lymphoma and myeloma.
We welcome all inquiries regarding our Clinical Trials and our basic research efforts.